Alizyme on brink of deal17th April 2007
Cambridge-based pharmaceutical company Alizyme is trying to secure licensing deals for four drugs in the latter stages of development.
If the deal goes ahead it could change the financial fortunes of the company which saw its shares fall steadily last year. However, following a change in executive management shares have begun to recover but what will really instill trust in new investors is if the company can secure a licensing deal. New CEO Tim McCarthy said he understood investors’ frustrations but added that 2007 looked like it was going to be a good year for the company.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Alizyme on brink of deal
Article Id: 2563
Date Added: 17th Apr 2007